STAT3 locus in inflammatory bowel disease and multiple sclerosis susceptibility

[1]  E. G. de la Concha,et al.  Evidence of epistasis between TNFRSF14 and TNFRSF6B polymorphisms in patients with rheumatoid arthritis. , 2010, Arthritis and rheumatism.

[2]  Ludwig Kappos,et al.  Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci , 2009, Nature Genetics.

[3]  L. Steinman.  A molecular trio in relapse and remission in multiple sclerosis , 2009, Nature Reviews Immunology.

[4]  A. Adamson,et al.  The Current STATus of lymphocyte signaling: new roles for old players. , 2009, Current opinion in immunology.

[5]  Sreeram V Ramagopalan,et al.  Epistasis among HLA-DRB1, HLA-DQA1, and HLA-DQB1 loci determines multiple sclerosis susceptibility , 2009, Proceedings of the National Academy of Sciences.

[6]  P. Matthews,et al.  Pathway and network-based analysis of genome-wide association studies in multiple sclerosis , 2009, Human molecular genetics.

[7]  J. Todd,et al.  Analysis of 17 autoimmune disease-associated variants in type 1 diabetes identifies 6q23/TNFAIP3 as a susceptibility locus , 2009, Genes and Immunity.

[8]  P. Deloukas,et al.  Investigation of Crohn's disease risk loci in ulcerative colitis further defines their molecular relationship. , 2009, Gastroenterology.

[9]  P. Tonali,et al.  The persistency of high levels of pSTAT3 expression in circulating CD4+ T cells from CIS patients favors the early conversion to clinically defined multiple sclerosis , 2008, Journal of Neuroimmunology.

[10]  Judy H. Cho,et al.  Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease , 2008, Nature Genetics.

[11]  Alastair Forbes,et al.  Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease , 2008, Nature Genetics.

[12]  Xuebin Liu,et al.  Loss of STAT3 in CD4+ T Cells Prevents Development of Experimental Autoimmune Diseases , 2008, The Journal of Immunology.

[13]  T. Karlsen,et al.  Replication of signals from recent studies of Crohn's disease identifies previously unknown disease loci for ulcerative colitis , 2008, Nature Genetics.

[14]  B. Franke,et al.  Novel association in chromosome 4q27 region with rheumatoid arthritis and confirmation of type 1 diabetes point to a general risk locus for autoimmune diseases. , 2007, American journal of human genetics.

[15]  V. Tomassini,et al.  The effect of disease activity on leptin, leptin receptor and suppressor of cytokine signalling-3 expression in relapsing–remitting multiple sclerosis , 2007, Journal of Neuroimmunology.

[16]  J. O’Shea,et al.  Signal transduction pathways and transcriptional regulation in the control of Th17 differentiation. , 2007, Seminars in immunology.

[17]  Hua Yu,et al.  Cutting Edge: An In Vivo Requirement for STAT3 Signaling in TH17 Development and TH17-Dependent Autoimmunity1 , 2007, The Journal of Immunology.

[18]  S. Gabriel,et al.  Risk alleles for multiple sclerosis identified by a genomewide study. , 2007, The New England journal of medicine.

[19]  Alastair Forbes,et al.  Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility , 2007, Nature Genetics.

[20]  Simon C. Potter,et al.  Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.

[21]  E. Urcelay,et al.  The 795CT polymorphism in osteopontin gene is not associated with multiple sclerosis in a Spanish population , 2007, Multiple sclerosis.

[22]  Thomas Lengauer,et al.  A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1 , 2007, Nature Genetics.

[23]  N. Bottini,et al.  Protein tyrosine phosphatase PTPN22 in human autoimmunity , 2007, Autoimmunity.

[24]  Judy H. Cho,et al.  A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene , 2006, Science.

[25]  X. Montalban,et al.  Plasma osteopontin levels in multiple sclerosis , 2005, Journal of Neuroimmunology.

[26]  R. Kiesslich,et al.  Activation Pattern of Signal Transducers and Activators of Transcription (STAT) Factors in Inflammatory Bowel Diseases , 2005, The American Journal of Gastroenterology.

[27]  E. Setakis.  Statistical analysis of the GAMES studies , 2003, Journal of Neuroimmunology.

[28]  S. Sawcer,et al.  Osteopontin gene and clinical severity of multiple sclerosis , 2003, Journal of Neurology.

[29]  C. Polman,et al.  Elevated osteopontin levels in active relapsing‐remitting multiple sclerosis , 2003, Annals of neurology.

[30]  J. Haines,et al.  Osteopontin polymorphisms and disease course in multiple sclerosis , 2003, Genes and Immunity.

[31]  E. Fikrig,et al.  STAT3 deletion during hematopoiesis causes Crohn's disease-like pathogenesis and lethality: A critical role of STAT3 in innate immunity , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[32]  Jorge R. Oksenberg,et al.  The Influence of the Proinflammatory Cytokine, Osteopontin, on Autoimmune Demyelinating Disease , 2001, Science.

[33]  S. Targan,et al.  A genome-wide search identifies potential new susceptibility loci for Crohn's disease , 1999 .

[34]  D. Silberberg,et al.  New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.

[35]  K. Mossman.  The Wellcome Trust Case Control Consortium, U.K. , 2008 .

[36]  J. Lennard-jones,et al.  Classification of inflammatory bowel disease. , 1989, Scandinavian journal of gastroenterology. Supplement.